These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Amaranthus spinosus Linn. inhibits mast cell-mediated anaphylactic reactions.
    Author: Patil SD, Patel MR, Patel SR, Surana SJ.
    Journal: J Immunotoxicol; 2012; 9(1):77-84. PubMed ID: 22145857.
    Abstract:
    The current study characterizes the mechanism by which the Amaranthus spinosus (Amaranthaceae) decreases mast cell-mediated anaphylactic reactions. Anaphylaxis is a typical hypersensitivity Type I reaction, sharing common mechanisms with asthma in its early and late phases. Mast cells are key as effector cells in hypersensitivity Type I reactions. A. spinosus has been traditionally used in the treatment of allergic bronchitis and asthma, but its role in mast cell-mediated anaphylactic reactions has not fully been investigated. This report investigated the potential effects of the ethyl acetate fraction of A. spinosus leaves (EAFAS) against a compound 48/80 (potent secretagogue)-induced systemic anaphylactic shock paradigm in a mouse model. In addition, rat peritoneal mast cells (RPMC) were used in in vitro studies to investigate the effect of EAFAS on compound 48/80-induced peritoneal mast cell degranulation and histamine release. When administration by the oral route-1 h before compound 48/80 injection-EAFAS (at dose from 0.001-1 g/kg) completely inhibited the induced anaphylactic shock. EAFAS at concentrations ranging 0.25-1 mg/ml dose-dependently attenuated rates of mast cell degranulation and histamine release from RPMC that were evoked by compound 48/80. The results of the present investigation indicated that EAFAS stabilizes the mast cell lipid bilayer membrane, thereby preventing the perturbation of membrane and the release of histamine. As a result of these anti-degranulating and anti-histaminic effects, it can be suggested that EAFAS may have a potential use in the prophylaxis and management of anaphylactic reactions.
    [Abstract] [Full Text] [Related] [New Search]